» Articles » PMID: 23929250

Human Papillomavirus Prevalence and Type Distribution in Invasive Cervical Cancer in Sub-Saharan Africa

Overview
Journal Int J Cancer
Specialty Oncology
Date 2013 Aug 10
PMID 23929250
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

In sub-Saharan Africa, invasive cervical cancer (ICC) incidence and mortality are among the highest in the world. This cross-sectional epidemiological study assessed human papillomavirus (HPV) prevalence and type distribution in women with ICC in Ghana, Nigeria, and South Africa. Cervical biopsy specimens were obtained from women aged ≥ 21 years with lesions clinically suggestive of ICC. Histopathological diagnosis of ICC was determined by light microscopy examination of hematoxylin and eosin stained sections of paraffin-embedded cervical specimens; samples with a confirmed histopathological diagnosis underwent HPV DNA testing by polymerase chain reaction. HPV-positive specimens were typed by reverse hybridization line probe assay. Between October 2007 and March 2010, cervical specimens from 659 women were collected (167 in Ghana, 192 in Nigeria and 300 in South Africa); 570 cases were histologically confirmed as ICC. The tumor type was identified in 551/570 women with ICC; squamous cell carcinoma was observed in 476/570 (83.5%) cases. The HPV-positivity rate in ICC cases was 90.4% (515/570). In ICC cases with single HPV infection (447/515 [86.8%]), the most commonly detected HPV types were HPV16 (51.2%), HPV18 (17.2%), HPV35 (8.7%), HPV45 (7.4%), HPV33 (4.0%) and HPV52 (2.2%). The prevalence of single and multiple HPV infections seemed higher among HIV-positive women and HPV type distribution appeared to differ according to tumor type and HIV status. In conclusion, HPV16, 18, 45 and 35 were the most common HPV types in sub-Saharan African women with ICC and HPV infections were more common in HIV-positive women.

Citing Articles

Examining barriers and facilitators of HPV vaccination in Nigeria, in the context of an innovative delivery model: a mixed-methods study.

Talabi O, Gilbert H, Fawzi M, Anorlu R, Randall T BMJ Public Health. 2025; 1(1):e000003.

PMID: 40017875 PMC: 11812689. DOI: 10.1136/bmjph-2023-000003.


Mapping the HPV Landscape in South African Women: A Systematic Review and Meta-Analysis of Viral Genotypes, Microbiota, and Immune Signals.

Maswanganye C, Mkhize P, Matume N Viruses. 2025; 16(12.

PMID: 39772200 PMC: 11680443. DOI: 10.3390/v16121893.


Natural History of High-Risk Human Papillomavirus in Kenyan and South African Women: Implications for Vaccination Campaigns and Cervical Cancer Screening Programs.

Happel A, Budiawan E, Onono M, Innes S, Palanee-Phillips T, Heuvel J Open Forum Infect Dis. 2024; 11(12):ofae690.

PMID: 39660028 PMC: 11631351. DOI: 10.1093/ofid/ofae690.


Global pattern of persistent human papillomavirus infection in female genital tract: An update system review and meta-analysis.

Zhao M, Kang P, Zhu L, Zhou D, Cui M, Zhang M iScience. 2024; 27(10):110991.

PMID: 39474077 PMC: 11519437. DOI: 10.1016/j.isci.2024.110991.


The interplay between programmed death ligand 1 (PD-L1) expression and human papillomavirus (HPV) genotypes in cervical carcinomas: findings of a Nigerian Tertiary Hospital.

Omenai S, Ajani M Pan Afr Med J. 2024; 48:90.

PMID: 39465196 PMC: 11512153. DOI: 10.11604/pamj.2024.48.90.42773.